| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |